215 related articles for article (PubMed ID: 38382647)
1. Vcp overexpression and leucine supplementation extend lifespan and ameliorate neuromuscular junction phenotypes of a SOD1G93A-ALS mouse model.
Huang TN; Shih YT; Yen TL; Hsueh YP
Hum Mol Genet; 2024 May; 33(11):935-944. PubMed ID: 38382647
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system.
Watanabe S; Ageta-Ishihara N; Nagatsu S; Takao K; Komine O; Endo F; Miyakawa T; Misawa H; Takahashi R; Kinoshita M; Yamanaka K
Mol Brain; 2014 Aug; 7():62. PubMed ID: 25167838
[TBL] [Abstract][Full Text] [Related]
3. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.
Basso M; Pozzi S; Tortarolo M; Fiordaliso F; Bisighini C; Pasetto L; Spaltro G; Lidonnici D; Gensano F; Battaglia E; Bendotti C; Bonetto V
J Biol Chem; 2013 May; 288(22):15699-711. PubMed ID: 23592792
[TBL] [Abstract][Full Text] [Related]
4. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
5. KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice.
Massopust R; Juros D; Shapiro D; Lopes M; Haldar SM; Taetzsch T; Valdez G
Neurobiol Dis; 2022 Jan; 162():105583. PubMed ID: 34902552
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
9. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis.
Fabbrizio P; Apolloni S; Bianchi A; Salvatori I; Valle C; Lanzuolo C; Bendotti C; Nardo G; Volonté C
Brain Pathol; 2020 Mar; 30(2):272-282. PubMed ID: 31376190
[TBL] [Abstract][Full Text] [Related]
10. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
11. Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS.
Rozas P; Pinto C; Martínez Traub F; Díaz R; Pérez V; Becerra D; Ojeda P; Ojeda J; Wright MT; Mella J; Plate L; Henríquez JP; Hetz C; Medinas DB
Acta Neuropathol Commun; 2021 Feb; 9(1):21. PubMed ID: 33541434
[TBL] [Abstract][Full Text] [Related]
12. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
[TBL] [Abstract][Full Text] [Related]
13. Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS.
Cappello V; Vezzoli E; Righi M; Fossati M; Mariotti R; Crespi A; Patruno M; Bentivoglio M; Pietrini G; Francolini M
Mol Cell Neurosci; 2012 Aug; 51(1-2):12-21. PubMed ID: 22800606
[TBL] [Abstract][Full Text] [Related]
14. Caspase 6 has a protective role in SOD1(G93A) transgenic mice.
Hogg MC; Mitchem MR; König HG; Prehn JH
Biochim Biophys Acta; 2016 Jun; 1862(6):1063-73. PubMed ID: 26976329
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
[TBL] [Abstract][Full Text] [Related]
16. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
17. Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.
Pozzi S; Thammisetty SS; Julien JP
Neurotherapeutics; 2018 Jul; 15(3):715-727. PubMed ID: 29790082
[TBL] [Abstract][Full Text] [Related]
18. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
19. Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS.
Xu H; Jia C; Cheng C; Wu H; Cai H; Le W
Free Radic Biol Med; 2022 Mar; 181():52-61. PubMed ID: 35114355
[TBL] [Abstract][Full Text] [Related]
20. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
